Leading pharmaceutical and IT companies have said they will quit Ireland if a proposed ban on so-called forever chemicals is ...

PFE's non-COVID drugs and contributions from new and newly acquired products are likely to have driven top-line growth in the ...

Pfizer's best-selling product by far in 2023 was Comirnaty, its latest-generation Covid vaccine. It alone brought in about $11.2 billion. Its second most profitable product was Eliquis ...

The goal of the Pfizer Medical LinkedIn page is to deliver timely communication of medical and scientific information regarding Pfizer products and the relevant diseases. By following this ...

Reeling off a list of several programmes ... drugs will continue to deliver for Pfizer however, and elsewhere the results were not so impressive. Oncology products fell 2% to $3.1 billion, dragged ...

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide.

The start of the new year is typically a time when people make big changes around health—and drug companies are no exception. Pfizer alone is raising prices on over 60 drugs, the most on the list.

The new portal could stir up more business for Pfizer drugs, though the company said patients won't be steered to its products and that decisions will remain with physicians. Driving the news ...

Weybridge-based Haleon is a consumer healthcare products manufacturer which owns ... Haleon was formed in 2019 as a joint venture of Pfizer and GSK PLC’s consumer health assets. It was listed on the ...

The latest disposal reduced Pfizer's interest in Haleon to 7.3% from 15%. JPMorgan and Morgan Stanley acted as joint global coordinators and joint bookrunners for the sale. GSK sold its remaining 4.2% ...